Evermay Wealth Management LLC Sells 737 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Evermay Wealth Management LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 21.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,624 shares of the healthcare conglomerate’s stock after selling 737 shares during the period. Evermay Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,381,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. WealthPlan Investment Management LLC lifted its stake in UnitedHealth Group by 774.0% during the 3rd quarter. WealthPlan Investment Management LLC now owns 673 shares of the healthcare conglomerate’s stock valued at $339,000 after acquiring an additional 596 shares in the last quarter. Millington Financial Advisors LLC boosted its holdings in UnitedHealth Group by 2.7% during the third quarter. Millington Financial Advisors LLC now owns 3,156 shares of the healthcare conglomerate’s stock worth $1,591,000 after purchasing an additional 82 shares during the last quarter. XML Financial LLC lifted its position in shares of UnitedHealth Group by 15.5% during the 3rd quarter. XML Financial LLC now owns 3,297 shares of the healthcare conglomerate’s stock worth $1,662,000 after buying an additional 442 shares in the last quarter. Callan Capital LLC boosted its stake in shares of UnitedHealth Group by 56.9% in the 3rd quarter. Callan Capital LLC now owns 833 shares of the healthcare conglomerate’s stock worth $420,000 after buying an additional 302 shares during the last quarter. Finally, Schechter Investment Advisors LLC lifted its holdings in UnitedHealth Group by 3.8% during the third quarter. Schechter Investment Advisors LLC now owns 15,488 shares of the healthcare conglomerate’s stock worth $7,809,000 after acquiring an additional 574 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. TD Cowen lowered their target price on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research report on Thursday, April 4th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Royal Bank of Canada lowered their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Finally, Truist Financial reissued a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Three analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $570.05.

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH traded down $8.66 on Friday, reaching $508.17. 2,528,228 shares of the company’s stock traded hands, compared to its average volume of 2,805,318. The stock has a 50-day simple moving average of $489.23 and a 200 day simple moving average of $510.55. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock has a market cap of $467.71 billion, a PE ratio of 31.06, a P/E/G ratio of 1.47 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business posted $6.26 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.